Exclusive

Publication

Byline

Japan's Chitose and Fujifilm Biosciences partner to drive global innovation and biopharma manufacturing

Singapore, Dec. 22 -- Japan-based Chitose Laboratory Corp. and Fujifilm Biosciences Inc. have announced a new strategic alliance that leverages the strengths of both companies in advancing biopharmace... Read More


Korea's Samsung Biologics expands US manufacturing capabilities after acquiring Human Genome Sciences from GSK

Singapore, Dec. 22 -- South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has announced that its wholly owned US subsidiary, Samsung Biologics Am... Read More


Australia develops new antimalarial drug candidate to address growing challenge of drug resistance

Singapore, Dec. 22 -- Researchers in Australia have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce malaria transmission... Read More


China's Jacobio inks immuno-oncology deal worth $1.9 B with AstraZeneca

Singapore, Dec. 22 -- China-based Jacobio Pharma has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73.AstraZeneca will receive exclusive development and commercia... Read More


Dubai's Mohammed Bin Rashid University of Medicine and Health Sciences introduces new nursing education programmes

Singapore, Dec. 22 -- Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the learning and discovery arm of Dubai Health, has introduced new nursing education programmes through the... Read More


Japan's Meiji Seika Pharma collaborates with MBC BioLabs for global innovation in drug discovery

Singapore, Dec. 19 -- Japan-based Meiji Seika Pharma has entered into a partnership agreement with MBC BioLabs which is a private organisation supporting the development of biotech startup companies i... Read More


Harbour BioMed, Bristol Myers Squibb strike $1B multi-specific antibody deal

Singapore, Dec. 19 -- China and US based HarbourBioMed has announced a multi-year, global strategic collaboration and license agreement with Bristol Myers Squibb to discover and develop next-generatio... Read More


Korean startup MEDI&GENE partners with Lilly to advance next-generation obesity therapeutics

Singapore, Dec. 19 -- MEDI&GENE, a South Korea-based biopharmaceutical company developing therapeutics for metabolic diseases, has entered into a catalyse agreement with EliLillyand Company toadvance ... Read More


Glenmark bags multi-regional rights to Hansoh Pharma's oncology drug for $1 B

Singapore, Dec. 18 -- Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of India-based Glenmark Pharmaceuticals, has entered into an exclusive license, collaboration and distribution agreement... Read More


numares Health enters ASEAN region with regulatory approval in Malaysia

Singapore, Dec. 18 -- Germany-based numares Health, the transformative metabolomics company pioneering multidimensional biomarker insights that deliver clinical pathways for optimal patient care, has ... Read More